283 results on '"McCormick, David L"'
Search Results
2. Childhood Leukemia: Electric and Magnetic Fields as Possible Risk Factors
3. Magnetic Fields and Mammary Cancer in Rodents: A Critical Review and Evaluation of Published Literature
4. 60 Hz Magnetic Fields Do Not Enhance Cell Killing by Genotoxic Chemicals in Ataxia Telangiectasia and Normal Lymphoblastoid Cells
5. Evaluation of the Developmental Toxicity of 60 Hz Magnetic Fields and Harmonic Frequencies in Sprague-Dawley Rats
6. Cell Viability and Growth in a Battery of Human Breast Cancer Cell Lines Exposed to 60 Hz Magnetic Fields
7. Supplemental Figure 1 from 5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?
8. Data from 5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?
9. Evaluation of the Toxicity and Potential Oncogenicity of Extremely Low Frequency Magnetic Fields in Laboratory Animal Models
10. Evaluation of the Potential Oncogenicity of Radiofrequency Fields in Experimental Animal Models
11. Modulation of Natural Killer Cell Function after Exposure to 60 Hz Magnetic Fields: Confirmation of the Effect in Mature B6 C3 F1 Mice
12. Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer
13. Abstract 706: Efficacy evaluation of BR-9001, a SMEDDS formulation of 3,3’-diindolylmethane, as an inhibitor of preneoplastic and neoplastic lesion development in the prostate of Hi-Myc mice
14. Oral and intravenous pharmacokinetics of 5-fluoro-2′-deoxycytidine and THU in cynomolgus monkeys and humans
15. Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs
16. The MNU Plus Testosterone Rat Model of Prostate Carcinogenesis
17. sj-docx-1-tpx-10.1177_01926233221096345 – Supplemental material for The MNU Plus Testosterone Rat Model of Prostate Carcinogenesis
18. sj-docx-4-tpx-10.1177_01926233221096345 – Supplemental material for The MNU Plus Testosterone Rat Model of Prostate Carcinogenesis
19. Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs
20. Direct quantitation of glucoraphanin in dog and rat plasma by LC–MS/MS
21. Chronic Toxicity/Oncogenicity Studies of 60 Hz Magnetic Fields in F344 Rats and B6C3F1 Mice: Final Survival, Body Weight, Clinical Observation, and Gross Pathology Data
22. Chemoprevention strategies for prostate cancer
23. Development of a novel, pan-variant aerosol intervention for COVID-19
24. Characterization of acute biliary hyperplasia in Fisher 344 Rats administered the Indole-3-Carbinol Analog, NSC-743380
25. Abstract LB225: Colon cancer preventive efficacy of licofelone and its analogue LFA-9 in PIRC rat model of FAP
26. Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats
27. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
28. Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys
29. Preclinical Evaluation of Carcinogenicity using the Rodent Two-Year Bioassay
30. Carcinogenicity Evaluations using Genetically Engineered Animals
31. Contributors
32. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance
33. Animal Studies in Carcinogen Identification: The Example of Power Frequency (50/60 Hz) Magnetic Fields
34. Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC–MS/MS and their pharmacokinetics in dogs
35. Determination and stability of CP-31398 in plasma from experimental animals by LC-MS/MS
36. Antioxidant Supplementation and Cancer Prevention
37. Electromagnetic Fields, Health Impacts of
38. Subchronic Toxicity and Toxicogenomic Evaluation of Tamoxifen Citrate + Bexarotene in Female Rats
39. Chemoprevention of rat prostate carcinogenesis by dietary 16α-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone
40. Reproductive toxicity assessment of chronic dietary exposure to soy isoflavones in male rats
41. Chronic Toxicity/Oncogenicity Evaluation of 60 Hz (Power Frequency) Magnetic Fields in B6C3F1 Mice
42. Chronic Toxicity/Oncogenicity Evaluation of 60 Hz (Power Frequency) Magnetic Fields in F344/N Rats
43. Abstract 2730: Exceptional activity of ARN-509 (apalutamide) in prostate cancer prevention in rats
44. H 2 S synthesis inhibitor prevents hypoxia‐evoked periodic breathing in spontaneous hypertensive rats
45. Abstract 3890: Interspecies comparison of in vitro endoxifen metabolism
46. Abstract 4931: Enhanced oral bioavailability of 3,3'-diindolylmethane administered in a self-microemulsifying drug delivery system (SMEDDS)
47. Abstract 4933: Six-month oral toxicity study of endoxifen in rats
48. Effect of cell phone radiofrequency radiation on body temperature in rodents: Pilot studies of the National Toxicology Program's reverberation chamber exposure system
49. Life-Time Dosimetric Assessment for Mice and Rats Exposed in Reverberation Chambers for the Two-Year NTP Cancer Bioassay Study on Cell Phone Radiation
50. A Radio Frequency Radiation Exposure System for Rodents Based on Reverberation Chambers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.